These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 39014082)

  • 41. Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis.
    Huang Y; Cao D; Zhang M; Yang Y; Niu G; Tang L; Shen Z; Zhang Z; Bai Y; Min D; He A
    Cell Oncol (Dordr); 2024 Oct; 47(5):1715-1733. PubMed ID: 38652223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
    Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
    Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods.
    Fu Z; Sun G; Li J; Yu H
    Medicine (Baltimore); 2024 Jun; 103(23):e38470. PubMed ID: 38847690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.
    Yao Q; Chen T
    J Cell Mol Med; 2020 Dec; 24(24):14293-14305. PubMed ID: 33108067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy.
    Wu Z; Yu J; Han T; Tu Y; Su F; Li S; Huang Y
    BMC Musculoskelet Disord; 2024 Jun; 25(1):437. PubMed ID: 38835052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma.
    Jin Y; Li L; Zhu T; Liu G
    Pathol Res Pract; 2019 Dec; 215(12):152688. PubMed ID: 31727503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets.
    Shao H; Ge M; Zhang J; Zhao T; Zhang S
    BMC Cancer; 2022 Mar; 22(1):288. PubMed ID: 35300639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
    Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
    Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
    J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo.
    Qiao S; Qi K; Liu C; Xu C; Ma J; Xu X; Li C; Wang Z
    J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
    Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
    Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-omic validation of the cuproptosis-sphingolipid metabolism network: modulating the immune landscape in osteosarcoma.
    Li Q; Fang J; Liu K; Luo P; Wang X
    Front Immunol; 2024; 15():1424806. PubMed ID: 38983852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.
    Liu C; Yi X
    Diagn Pathol; 2020 Jul; 15(1):96. PubMed ID: 32709240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.
    Scott MC; Temiz NA; Sarver AE; LaRue RS; Rathe SK; Varshney J; Wolf NK; Moriarity BS; O'Brien TD; Spector LG; Largaespada DA; Modiano JF; Subramanian S; Sarver AL
    Cancer Res; 2018 Jan; 78(2):326-337. PubMed ID: 29066513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.